OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
OXON Epidemiology leads a group of international European academics and clinicians to conduct the ‘RAPID COVID-19’ research programme of hospitalised COVID-19 patients.
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
Visit our booth B36 at DIA. If you are interested in an optimal safety (PASS) study, OXON’s expert team, supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene and Tropical Medicine can help you face your PASS and PAES challenges.
OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.
OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.
We were delighted to win first prize in the BRACE poster award for a novel hybrid design for a 6-country study approved by PRAC at ISPE International Conference in Prague.
